Today: 7 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 22 December 2025 - 23 December 2025

Warner Bros. Discovery (WBD) Series A Stock Today: Paramount’s $30 Bid Gets Larry Ellison Backstop as Netflix Deal Enters Crunch Time

Warner Bros. Discovery (WBD) Series A Stock Today: Paramount’s $30 Bid Gets Larry Ellison Backstop as Netflix Deal Enters Crunch Time

December 23, 2025 — Warner Bros. Discovery, Inc. Series A common stock (NASDAQ: WBD) traded around $28.98 in U.S. trading on Tuesday, hovering between two competing takeover paths: Netflix’s agreed cash-and-stock combination for WBD’s studios and streaming assets, and Paramount Skydance’s hostile all-cash tender offer for the whole company. The latest catalyst hit late Monday and spilled into Tuesday’s market: Paramount Skydance amended its $30-per-share offer, adding a high-profile financing enhancement—an “irrevocable personal guarantee” from Oracle co-founder Larry Ellison covering $40.4 billion of equity financing—while keeping the headline price unchanged. Reuters+2Wall Street Journal+2 What changed on December 23—and why WBD
23 December 2025
·····
Teck Resources Stock (NYSE: TECK): Anglo Merger Updates, Record Copper Prices, and What to Watch on December 23, 2025

Teck Resources Stock (NYSE: TECK): Anglo Merger Updates, Record Copper Prices, and What to Watch on December 23, 2025

Teck Resources Limited (TSX: TECK.A, TECK.B; NYSE: TECK) is ending 2025 in the rarest of market habitats: an event-driven mining stock with a macro tailwind and a very real operational “boss fight” still underway at its flagship copper mine. Teck Resources Limited+1 As of December 23, 2025, Teck’s U.S.-listed shares were trading around $46.76, near the top of their 52‑week range ($28.32–$47.06)—a move that puts the stock’s merger timeline and copper exposure under a brighter spotlight heading into year-end. Investing.com Below is a consolidated roundup of the most market-moving news, forecasts, and analyst narratives in circulation as of 23.12.2025, and
23 December 2025
······
ServiceNow (NOW) Stock Drops After $7.75 Billion Armis Deal: Today’s News, Analyst Forecasts, and What’s Next (Dec. 23, 2025)

ServiceNow (NOW) Stock Drops After $7.75 Billion Armis Deal: Today’s News, Analyst Forecasts, and What’s Next (Dec. 23, 2025)

ServiceNow, Inc. (NYSE: NOW) stock traded lower on Tuesday, December 23, 2025, after the enterprise software leader announced its largest acquisition to date: a $7.75 billion all‑cash agreement to buy cyber exposure management specialist Armis. The move is designed to deepen ServiceNow’s security and risk footprint—especially across operational technology (OT), IoT, and medical devices—at a moment when AI adoption is expanding corporate “attack surfaces” and making cyber governance a board-level priority. ServiceNow Investor Relations+1 But Wall Street’s first reaction was cautious. ServiceNow shares were down roughly 3% in midday trading in broader market coverage, and the stock hovered around $152.5
23 December 2025
··
Warner Bros. Discovery Stock (WBD) Today: Paramount’s $30 Bid vs. Netflix Deal, Fresh Deal Updates, and Analyst Forecasts (Dec. 23, 2025)

Warner Bros. Discovery Stock (WBD) Today: Paramount’s $30 Bid vs. Netflix Deal, Fresh Deal Updates, and Analyst Forecasts (Dec. 23, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) stock is trading like a company caught in the gravitational field of two giants—because it is. Shares hovered around $28.89 in Tuesday trading (Dec. 23, 2025) as investors weighed a strengthened hostile bid from Paramount Skydance against Warner Bros. Discovery’s board-backed agreement with Netflix. Reuters At the center of today’s move is a simple question with very not-simple implications: Which deal—if any—actually closes? That uncertainty is what’s setting the tone for WBD stock right now, and it’s also why traditional “fundamentals-first” stock narratives have taken a back seat to merger math, financing certainty, and
23 December 2025
·····
Clearwater Analytics (CWAN) Stock News Today: $24.55 Take-Private Deal, Latest Forecasts, and What Investors Are Watching (Dec. 23, 2025)

Clearwater Analytics (CWAN) Stock News Today: $24.55 Take-Private Deal, Latest Forecasts, and What Investors Are Watching (Dec. 23, 2025)

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) stock is trading in deal-mode on December 23, 2025, after the company agreed to be acquired in an all-cash $24.55-per-share transaction led by private equity firms Permira and Warburg Pincus, with support from Francisco Partners and participation from Temasek. Reuters+2SEC+2 For shareholders, the headline is simple: if the transaction closes as planned, CWAN holders get $24.55 in cash. For everyone trying to understand the “why,” the “what could change,” and the “what happens next,” the story is a lot more interesting—because it blends activist pressure, an acquisition-fueled strategy shift, and a market that never
23 December 2025
··
Warner Bros. Discovery Stock (WBD) Surges Into a Deal-Driven Crossroads: Netflix Merger, Paramount’s Ellison-Backed Bid, and Wall Street Forecasts (Dec. 23, 2025)

Warner Bros. Discovery Stock (WBD) Surges Into a Deal-Driven Crossroads: Netflix Merger, Paramount’s Ellison-Backed Bid, and Wall Street Forecasts (Dec. 23, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is trading less like a traditional media stock and more like a live, headline-powered referendum on which future it gets: a Netflix tie-up for its crown-jewel entertainment assets, or a full-company buyout pitched by Paramount Skydance—now reinforced by a massive personal guarantee from Oracle co-founder Larry Ellison. As of Tuesday, Dec. 23, WBD shares were around $28.75. That price matters, because it sits in the gravitational pull of two competing proposals—and it reflects how investors are weighing a higher nominal offer against deal certainty, timing, break fees, and regulatory risk. What’s moving WBD stock
23 December 2025
·····
Paramount Skydance Corporation Stock (PSKY): Why Shares Are in Focus on Dec. 23, 2025 as the Company Doubles Down on a Warner Bros. Discovery Bid

Paramount Skydance Corporation Stock (PSKY): Why Shares Are in Focus on Dec. 23, 2025 as the Company Doubles Down on a Warner Bros. Discovery Bid

Paramount Skydance Corporation stock (NASDAQ: PSKY) is back in the spotlight on December 23, 2025, after the company sharpened the financing behind its high-profile attempt to acquire Warner Bros. Discovery (NASDAQ: WBD)—and as major shareholders and analysts weigh whether the sweetened terms are enough to change the outcome of one of Hollywood’s most consequential deal fights. The short version: PSKY hasn’t raised its headline $30-per-share cash offer for WBD, but it strengthened the credibility of its funding with an “irrevocable personal guarantee” of $40.4 billion from Oracle co-founder Larry Ellison, increased its regulatory reverse termination fee, and extended the tender
23 December 2025
···
DJT Stock News (Dec. 23, 2025): Trump Media Whiplash Continues After TAE Fusion Merger Surge—What Investors Are Watching Next

DJT Stock News (Dec. 23, 2025): Trump Media Whiplash Continues After TAE Fusion Merger Surge—What Investors Are Watching Next

Trump Media & Technology Group Corp. (NASDAQ: DJT) is back in its natural habitat: extreme volatility. After a blistering, headline-driven run last week tied to a surprise $6 billion all-stock merger plan with nuclear fusion developer TAE Technologies, DJT abruptly gave back a chunk of those gains—highlighting the stock’s unusual mix of speculation, politics, and now… fusion-energy ambition. Reuters+2SEC+2 As of the latest regular-session close (Monday, Dec. 22), DJT finished at $14.41, down 10.44% on the day, following Thursday’s +41.93% surge and Friday’s +8.28% continuation move. StockAnalysis+1 Early Tuesday (Dec. 23), DJT indicated a modest rebound in premarket trading—underscoring how
23 December 2025
··
Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

London-listed Anglo American plc is ending 2025 with its investment story compressed into two big levers: a once-in-a-generation copper market and a once-in-a-generation corporate reshuffle. On December 23, those levers are both moving. The company has published provisional 2026 dividend timetables, while the proposed Anglo‑Teck “merger of equals” has cleared major procedural and political hurdles in Canada—yet still faces the final, fussy gatekeepers of global competition and regulatory approvals. At the same time, copper is flirting with the $12,000/ton level amid supply disruptions and tariff-driven distortions that have split the market into “metal-rich” and “metal-starved” regions. Investing.com+1 What follows is
23 December 2025
···
BP PLC Stock on Dec. 23, 2025: Share Price, New CEO Meg O’Neill, Castrol Sale Talks, Buybacks, and 2026 Oil Outlook

BP PLC Stock on Dec. 23, 2025: Share Price, New CEO Meg O’Neill, Castrol Sale Talks, Buybacks, and 2026 Oil Outlook

BP PLC stock is ending 2025 with a familiar mix of Big Oil fundamentals and BP-specific drama: a surprise leadership reset, a high-stakes divestment agenda (with Castrol at the center), and a market that’s trying to price 2026 oil demand against an oversupplied-looking crude backdrop. As of Tuesday, December 23, 2025, investors are digesting what BP’s board appears to be signaling: “more discipline, fewer detours.” The big question for BP shares (LSE: BP. / NYSE: BP) is whether that message translates into higher cash flow, lower net debt, and steadier shareholder returns—or simply another chapter in the company’s multi-year strategic
23 December 2025
···
Trump Media & Technology Group (DJT) Stock on Dec. 22, 2025: Fusion-Merger Rally Fades, Key Deal Details, and Today’s Forecasts

Trump Media & Technology Group (DJT) Stock on Dec. 22, 2025: Fusion-Merger Rally Fades, Key Deal Details, and Today’s Forecasts

Dec. 22, 2025 — Trump Media & Technology Group Corp. (Nasdaq / NYSE Texas: DJT) is back in its natural habitat: extreme volatility. After rocketing higher late last week on news of a surprise pivot into nuclear fusion, DJT stock dropped sharply on Monday, Dec. 22, giving back a meaningful portion of those gains. Barron’s As of 18:43 UTC on Dec. 22, DJT traded at $14.51, down $1.58 (-9.82%) from the prior close, with an intraday range of $14.325 to $17.13 on volume of 27.35 million shares. What’s driving the move is not a new ad product at Truth Social,
22 December 2025
···
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

December 22, 2025 — Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) traded higher Monday as the company’s takeover battle intensified, with Paramount Skydance revising its hostile bid and Netflix disclosing fresh financing arrangements tied to its agreed deal with Warner’s studio-and-streaming assets. Nasdaq+2Reuters+2 WBD shares were recently around $28.70, after ranging between $27.78 and $29.31 in Monday’s session, as investors weighed the value of Paramount’s $30-per-share all-cash proposal against the certainty, structure, and regulatory path of the Netflix transaction. Reuters+1 Why Warner Bros. Discovery stock is moving on Dec. 22, 2025 Two headline developments hit the market
22 December 2025
··
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) is in the spotlight on December 22, 2025, after the company confirmed it has agreed to be acquired in an all-cash take-private transaction valued at about $8.4 billion (including debt). Shareholders are set to receive $24.55 per share in cash, a headline number that has quickly become the market’s “gravity well” for the stock. Reuters+2CWAN+2 With the deal now public, the CWAN story shifts from the usual quarterly beat/miss drama to a more deal-driven narrative: merger timelines, regulatory approvals, a “go-shop” window for competing bids, and whether the stock trades at (or below) the
22 December 2025
··
Karman Holdings (KRMN) Stock Surges on Dec. 22, 2025: What Today’s Rally, New Forecasts, and the Five Axis Deal Mean for Investors

Karman Holdings (KRMN) Stock Surges on Dec. 22, 2025: What Today’s Rally, New Forecasts, and the Five Axis Deal Mean for Investors

Karman Holdings Inc. (NYSE: KRMN) stock is having a loud Monday. In midday trading on December 22, 2025, KRMN stock jumped roughly 8%–9% into the high-$70s, putting the aerospace-and-defense newcomer among the market’s notable winners as risk appetite improved and small caps outperformed. StockAnalysis+2Benzinga+2 So what’s actually behind the move—and what do the newest forecasts and analyses imply for where Karman Holdings stock could go next? Below is a comprehensive snapshot of today’s news and analysis (Dec. 22, 2025), plus the freshest Wall Street outlooks that are shaping the narrative around KRMN right now. KRMN stock today: price, momentum, and
22 December 2025
···
Warner Bros. Discovery Stock (WBD) Today: Paramount Adds Larry Ellison’s $40.4B Guarantee, Netflix Locks In Deal Financing — What It Means for Shares (Dec. 22, 2025)

Warner Bros. Discovery Stock (WBD) Today: Paramount Adds Larry Ellison’s $40.4B Guarantee, Netflix Locks In Deal Financing — What It Means for Shares (Dec. 22, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) stock is trading like a referendum on one question: which bidder (if any) ultimately wins one of the biggest media takeovers in history. As of Dec. 22, 2025, WBD shares were last at $27.77, after swinging between $27.07 and $29.31 in a volatile session. The day’s catalyst is straightforward: Paramount Skydance doubled down on its hostile takeover attempt with a major financing upgrade—an “irrevocable personal guarantee” from Oracle co-founder Larry Ellison covering $40.4 billion of equity financing—while Netflix moved to strengthen its own bid by refinancing a large piece of the bridge funding backing
22 December 2025
·····
Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stock is no longer trading like a typical biotech momentum name—at least not this week. As of December 22, 2025, the stock is hovering around $14.18, tightly anchored to the $14.50 per-share all-cash buyout BioMarin Pharmaceutical has agreed to pay. Investing.com+1 That tight range is the market’s way of saying: “We believe the deal is real, but not free money.” The remaining gap between today’s trading price and the $14.50 cash consideration reflects the time value of waiting, plus the risk (however small) that something delays or disrupts closing. Below is a full, publication-ready breakdown
22 December 2025
···
ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

Dec. 22, 2025 — ProPhase Labs, Inc. (NASDAQ: PRPH) is hitting one of the most consequential “inflection points” a micro-cap stock can face: a Nasdaq compliance deadline, a reverse stock split that reshapes how the ticker trades, and a newly announced non-binding reverse merger proposal that could dramatically change what ProPhase Labs is going forward. Reuters+3NASDAQ Trader+3ProPhase Labs, Inc.+3 In plain English: PRPH investors are watching two parallel storylines unfold at once—(1) staying listed and (2) potentially being “re-made” via a reverse merger with Europe-based Advanced Biological Laboratories S.A. (ABL). ProPhase Labs, Inc.+2Euronext Live+2 Why ProPhase Labs stock is in
22 December 2025
··
Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18 on Dec. 22, the market is now pricing FOLD mostly on closing probability and timing, not clinical catalysts. Investing.com+1 That change in narrative is already visible in analyst actions dated 22.12.2025: TD Cowen downgraded Amicus to Hold and reset its target to $14.50, essentially treating the stock as a merger-arbitrage position rather than a standalone biotech. Investing.com Below is the
22 December 2025
··
Luminar Technologies (LAZR) Stock: Chapter 11 Sale Process, $110M Photonics Deal, and Nasdaq Delisting Countdown (Dec. 22, 2025)

Luminar Technologies (LAZR) Stock: Chapter 11 Sale Process, $110M Photonics Deal, and Nasdaq Delisting Countdown (Dec. 22, 2025)

Updated for Dec. 22, 2025 — Luminar Technologies, Inc. (NASDAQ: LAZR) is in the middle of a court-supervised restructuring that has turned the stock into a high-volatility, headline-driven trade. The company filed for Chapter 11 bankruptcy on Dec. 15, lined up a $110 million all-cash deal to sell its photonics subsidiary, and is now facing an imminent Nasdaq delisting—while the share price whipsaws on extraordinary volume. Luminar Technologies, Inc.+2Luminar Technologies, Inc.+2 What matters for investors on Dec. 22 isn’t a typical earnings “beat or miss.” It’s the bankruptcy timeline, the auction process, and the harsh reality of capital structure math:
22 December 2025
····
Eaton Stock (ETN) Week Ahead: Data Center Power Expansion, Boyd Cooling Deal, and Analyst Targets to Watch (Dec. 22–26, 2025)

Eaton Stock (ETN) Week Ahead: Data Center Power Expansion, Boyd Cooling Deal, and Analyst Targets to Watch (Dec. 22–26, 2025)

Eaton Corporation plc (NYSE: ETN) heads into the holiday-shortened trading week with investors weighing two competing forces: a powerful multi-year “grid-to-chip” demand story tied to AI data centers and electrification, and near-term questions about valuation, cyclical end-markets, and deal execution. As of the latest available pricing (Friday’s close), ETN traded around $317.80. In the most notable move of the past week, Eaton shares fell 4.28% on Wednesday, December 17, closing at $315.82, with trading volume reported well above the recent average—an attention-getting signal heading into a low-liquidity, year-end tape. MarketWatch Below is a week-ahead briefing built from the most recent
22 December 2025
···
1 2 3 4 5 … 20

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
New York, Feb 7, 2026, 09:39 EST — Market closed. Apple Inc (AAPL.O) shares ended Friday up 0.8% at $278.12 after swinging between $276.92 and $280.90, before dipping 0.3% in after-hours trading. U.S. markets are shut on Saturday, but the stock goes into Monday with a familiar question back on the tape: will Apple raise iPhone prices, or eat higher costs. (Investing.com data) The immediate pressure point is memory. A tightening supply of DRAM — the memory chips that help phones run power-hungry apps smoothly — is pushing up component costs just as investors are re-pricing the economics of the
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Go toTop